SRC and breast carcinoma: Previous studies on lung, gastric, cervical, and breast cancers have shown that miR-150-5p promotes cell proliferation and migration by targeting the SRC kinase signaling inhibitor 1 (SRCIN1), a negative regulator of SRC and an experimentally validated direct target of miR-150-5p [23,28,76].